openPR Logo
Press release

Vykee Nutrition Launches Premium US-Made Supplement Line Inspired by Nordic Strength and Vitality

04-03-2025 11:24 PM CET | Sports

Press release from: ABNewswire

Vykee Nutrition Launches Premium US-Made Supplement Line

Image: https://www.abnewswire.com/upload/2025/04/a8beba61f33a7f17227da75d4d180771.jpg

Cincinnati, OH - Apr 3, 2025 - Vykee Nutrition, a new American-made wellness brand rooted in the enduring spirit of Nordic Vikings, today announced the official launch of its premium supplement line. The brand offers high-quality vitamins, minerals, and specialty supplements proudly manufactured in the USA, designed to help modern consumers reclaim their health and vitality.

Born in the USA and inspired by the principles of strength, resilience, and natural wellness that defined the Viking approach to life, Vykee Nutrition empowers individuals to become the best versions of themselves through meticulously formulated supplements.

"Our mission is simple yet profound: to provide modern wellness warriors with the highest quality nutritional tools to conquer their health goals," said JJ Davis, founder and CEO of Vykee Nutrition [https://vykee.com/]. "We've combined ancient wisdom with modern science and transparency to create supplements that align with the discipline and passion it takes to achieve peak physical and mental performance."

More Than Just Supplements: Tools for Modern Vikings

Vykee Nutrition's initial product lineup features over 20 essential supplements including Vitamin D3+K2, Turmeric Curcumin, Creatine, NAC, Glutamine, Vitamin B1, Potassium, and Iron. Each product is formulated to support specific wellness needs from immune function and energy production to joint health and muscle growth.

The company emphasizes that with Vykee Nutrition, customers aren't just getting supplements-they're getting the tools to conquer their goals with the same steadfast determination as the great male and female Vikings of the past.

All Vykee Nutrition products are:

* Proudly sourced and manufactured in the USA
* Manufactured in a GMP certified and FDA registered facility
* Are NSF certified for sport
* Meticulously formulated for the highest levels of bioavailability
* Gluten-free for enhanced digestibility
* Feature QR codes on every label that provide testing results from third party labs

Connection to Nature and Transparency

Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXexn4Gub_nbyYxS8eiWfOs7iq1ucSijT9fRZ8eK84e6fnFR-cgkQ4KcUNV3WAe-AVgt7n90lxCTp5mlmuXAV1YFZxd42IMI54QMiXehLl9svGrk9_QkQGVbCtAkJEhdZADw1Nhz?key=D7kSMFkxDdAgUoLjQy33dEy-

"We believe in transparency and a connection to nature that mirrors the Viking approach to life," added JJ Davis "Each of our products features a custom QR code that can be scanned to see the full list of ingredients, empowering consumers to make informed choices about their wellness journey."

Celebrating the Launch with Special Offers

To celebrate its official launch, Vykee Nutrition is offering up to 25% off during its Winter Sale, along with free shipping on all orders. Products are also available at the Vykee Nutrition storefront at Amazon.

About Vykee Nutrition

Headquartered in Cincinnati, Ohio, Vykee Nutrition was born from a passion for combining ancient wisdom with modern nutritional science. Inspired by the legendary Nordic Vikings who thrived on strength and resilience, Vykee creates premium, US-made supplements for those seeking to conquer their personal health goals. Vykee is produced in a GMP-certified and NSF certified for sport facility, ensuring the highest standards of safety, purity, and potency.

For more information, visit https://www.vykee.com or contact help@vykee.com

Media Contact:

JJ Davis

800-718-0803

help@vykee.com

5880 Hillside

Ave Cincinnati, Ohio 45233

Media Contact
Company Name: Vykee Nutrition
Contact Person: JJ Davis
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=vykee-nutrition-launches-premium-usmade-supplement-line-inspired-by-nordic-strength-and-vitality]
City: Cincinnati
State: Ohio
Country: United States
Website: http://www.vykee.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vykee Nutrition Launches Premium US-Made Supplement Line Inspired by Nordic Strength and Vitality here

News-ID: 3954828 • Views:

More Releases from ABNewswire

Myelofibrosis Market Outlook 2034 - Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight
Myelofibrosis Market Outlook 2034 - Clinical Trials, Market Size, Medication, Pr …
Myelofibrosis Market Include Incyte Corporation, Keros Therapeutics, Karyopharm Therapeutics, Celgene Corporation, PharmaEssentia, Novartis, SecuraBio, Pharmaxis, Novartis Oncology, AstraZeneca, Cellenkos, Jacobio Pharmaceuticals, Ohmoncology, Geron Corporation, AbbVie, Sierra Oncology, Galecto Biotech, Actuate Therapeutics, Kartos Therapeutics, Menarini Group, Telios Pharma, Novartis Pharmaceuticals, NS Pharma, Celgene/Bristol-Myers Squibb, MorphoSys, Imago BioSciences, Roche, and others. Myelofibrosis Market Summary The Myelofibrosis market in the 7MM is set to grow significantly, rising from USD 2.6 billion in 2025 to USD
Kid Connecticut Showcases Full Catalog of Authentic Innovation
Kid Connecticut Showcases Full Catalog of Authentic Innovation
Rising independent artist Kid Connecticut is making waves across streaming platforms with a catalog that blends sharp lyricism, genre-bending production, and unfiltered authenticity. With every release, Kid Connecticut has built a reputation as a creator who refuses to follow the industry blueprint. Instead, he offers listeners a body of work that reflects growth, resilience, and originality while capturing the reality of an artist evolving in real time. From his earliest tracks
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2025: Innovations by 180+ Global Leaders - DelveInsight | Featuring GenSight Biologics, Ultragenyx Pharmaceutical, MeiraGTx
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2025: Innovations …
Adeno-Associated Virus (AAV) Vectors in Gene Therapy companies are Nanoscope Therapeutics, REGENXBIO, Astellas Gene Therapy, GeneCradle Therapeutics, Asklepios BioPharmaceutical, 4D Molecular Therapeutics, Adverum Biotechnologies, Rocket Pharmaceuticals, Innostellar Biotherapeutics, Passage Bio, Aspa Therapeutics, Solid Biosciences, Lantu Biopharma, Ascidian Therapeutics, Decibel Therapeutics, Sio Gene Therapies, and others. As the use of Adeno-Associated Virus (AAV) vectors in gene therapy expands globally, there is increasing demand for safer and more effective treatment options, addressing conditions
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market: Epidemiology, Therapies, Companies, DelveInsight | Key players include AstraZeneca, Boehringer Ingelheim, Genentech/Roc
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market: …
The total market size of EGFR mNSCLC in the 7MM was ~USD 4,000 million in 2023. Emerging EGFR-NSCLC therapies-such as TAGRISSO, GILOTRIF/GIOTRIF, TARCEVA, RYBREVANT, VIZIMPRO, IRESSA, PORTRAZZA, Aumolertinib, Zipalertinib, Furmonertinib, BDTX-1535, Dato-DXd, JIN-A02, NX-019, STX-721, and ORIC-11-are expected to drive market growth in the coming years. DelveInsight's report, "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Market Insights, Epidemiology, and Market Forecast-2034," provides a comprehensive analysis of EGFR-NSCLC, including historical

All 5 Releases